What Are Other, Non-Osteoporosis Bone Disorders?<\/h2>\n![\"Paget's](\"https:\/\/www.saintjohnscancer.org\/endocrine\/wp-content\/uploads\/sites\/3\/2026\/05\/Pagets-Bone-Disease.jpg\")
Paget’s Bone Disease is one of many bone disorders that can cause complications, fractures, or arthritis.<\/figcaption><\/figure>\n\nOther bone disorders refer to less common conditions that disrupt normal bone formation, remodeling, or mineralization. Unlike osteoporosis\u2014which primarily involves loss of bone density\u2014these disorders may affect bone structure, mineral balance, or the way bone tissue is built and repaired. Many are closely linked to endocrine, metabolic, renal, or oncologic processes, making accurate diagnosis essential for effective treatment.\n<\/p>\n
\nHow These Disorders Affect Bone Health<\/h3>\n
\n These conditions may alter the shape, strength, or mineral content of bone, leading to pain, deformity, or increased fracture risk. Some disorders interfere with calcium or phosphate regulation, while others affect the way bone cells remodel tissue. Understanding the underlying cause helps guide treatment and long\u2011term monitoring.\n <\/p>\n
Why Specialized Evaluation Matters<\/h3>\n
\n Because many bone disorders overlap with endocrine or metabolic conditions, evaluation by an endocrine specialist is often necessary. Our team works closely with nephrology, oncology, and genetics when needed to ensure a complete and accurate diagnosis.\n <\/p>\n<\/div>\n
Types of Bone Disorders We Evaluate<\/h2>\n
\nA variety of metabolic and structural bone disorders fall under this category. Each condition affects bone differently and requires a tailored approach to diagnosis and treatment. Below are some of the most common disorders evaluated by our endocrine team.\n<\/p>\n
\nOsteomalacia<\/h3>\n![\"Osteomalacia](\"https:\/\/www.saintjohnscancer.org\/endocrine\/wp-content\/uploads\/sites\/3\/2026\/05\/Osteomalacia-deformityv.jpg\")
Osteomalacia can result in pelvic deformities, including softening of the pelvic girdle creating inward pressure from the femoral heads.<\/figcaption><\/figure>\n\n Osteomalacia occurs when bones fail to mineralize properly, often due to vitamin D deficiency, malabsorption, or chronic kidney disease. This leads to soft, weakened bones that may cause pain, muscle weakness, or fractures. Treatment focuses on correcting the underlying deficiency or metabolic imbalance.\n <\/p>\n
Paget\u2019s Disease of Bone<\/h3>\n
\n Paget\u2019s disease is a chronic condition in which bone remodeling occurs too rapidly, producing enlarged but structurally weak bone. It most commonly affects the spine, pelvis, skull, and long bones. Early diagnosis and treatment can help prevent complications such as fractures or arthritis.\n <\/p>\n
Renal Osteodystrophy<\/h3>\n
\n Renal osteodystrophy is a bone disorder related to chronic kidney disease, caused by imbalances in calcium, phosphorus, and parathyroid hormone (PTH). Because it is closely tied to endocrine function, evaluation often includes assessment of parathyroid disease<\/a> and mineral metabolism.\n <\/p>\nHypophosphatemia<\/h3>\n
\n Hypophosphatemia is characterized by low phosphate levels, which can impair bone strength and lead to fractures or bone pain. It may be inherited or acquired and often requires specialized metabolic evaluation to determine the cause.\n <\/p>\n
Osteoporosis<\/h3>\n
\n Osteoporosis develops due to a combination of biological, hormonal, and lifestyle factors. See Osteoporosis<\/u><\/a> for additional information.\n <\/p>\n<\/div>\nBone Metastases from Cancer<\/h2>\n
\nBone metastases occur when cancer spreads from its original site to the bone. Although not a primary bone disorder, metastases can mimic metabolic bone disease on imaging or laboratory testing. Breast, prostate, lung, kidney, and thyroid cancers are among the most common sources of bone metastases.\n<\/p>\n
\nHow Bone Metastases Affect Bone Health<\/h3>\n![\"Bone](\"https:\/\/www.saintjohnscancer.org\/endocrine\/wp-content\/uploads\/sites\/3\/2026\/05\/Bone-metastasis-from-cancer.jpg\")
Bone metastasis from cancer can present one or more symptoms such as bone pain or fractures.<\/figcaption><\/figure>\n\n When cancer cells spread to bone, they can weaken the bone structure and increase the risk of fractures. Patients may experience bone pain, spinal cord compression, or elevated calcium levels. These complications require prompt evaluation and coordinated care.\n <\/p>\n
\n- Bone pain<\/li>\n
- Fractures<\/li>\n
- Spinal cord compression<\/li>\n
- Elevated calcium levels<\/li>\n<\/ul>\n
Coordinated Care With Oncology<\/h3>\n
\n Because bone metastases can resemble metabolic bone disorders, endocrine specialists often collaborate with oncology teams to evaluate bone health, manage calcium abnormalities, and reduce fracture risk. This multidisciplinary approach ensures comprehensive care for patients with cancer\u2011related bone involvement.\n <\/p>\n<\/div>\n
Fibrous Dysplasia<\/h2>\n
\nFibrous dysplasia is a rare bone disorder in which normal bone is replaced with fibrous tissue, leading to weakened bone structure and potential deformity. It may involve a single bone (monostotic) or multiple bones (polyostotic) and can be associated with endocrine abnormalities in certain syndromic forms.\n<\/p>\n
\nSymptoms of Fibrous Dysplasia<\/h3>\n
\n Symptoms vary depending on the bones involved and may include pain, fractures, deformity, or limb length differences. Some individuals have mild disease, while others require long\u2011term monitoring and supportive care.\n <\/p>\n
\n- Bone pain<\/li>\n
- Fractures<\/li>\n
- Bone deformity<\/li>\n
- Limb length differences<\/li>\n<\/ul>\n
How It Is Managed<\/h3>\n
\n Management focuses on monitoring bone integrity, reducing symptoms, and addressing associated hormonal conditions when present. Our endocrine team evaluates for related disorders and coordinates care with orthopedics and genetics when needed.\n <\/p>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-none","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":"
Signs and Symptoms of Bone Disorders<\/h2>\n
\nBone disorders can present in many ways depending on the underlying cause and severity. Some individuals experience noticeable symptoms, while others are diagnosed after abnormal imaging or laboratory findings. Recognizing early signs can help prevent complications.\n<\/p>\n
\nCommon Symptoms<\/h3>\n![\"Signs](\"https:\/\/www.saintjohnscancer.org\/endocrine\/wp-content\/uploads\/sites\/3\/2026\/05\/Signs-and-Symptoms-of-Bone-Disorders.jpg\")
Your primary care physician may refer you to an endocrine specialist to address bone related conditions.<\/figcaption><\/figure>\n\n Symptoms may include persistent bone pain, recurrent fractures, muscle weakness, or skeletal deformities. Children and adolescents may experience delayed growth or difficulty walking. Any unexplained bone symptoms should prompt evaluation.\n <\/p>\n
\n- Persistent bone pain or tenderness<\/li>\n
- Recurrent or unexplained fractures<\/li>\n
- Muscle weakness<\/li>\n
- Skeletal deformities<\/li>\n
- Loss of height<\/li>\n
- Difficulty walking<\/li>\n
- Delayed growth in children or adolescents<\/li>\n<\/ul>\n<\/div>\n
Causes and Risk Factors<\/h2>\n
\nBone disorders may arise from hormonal imbalances, metabolic abnormalities, chronic disease, or genetic factors. Identifying the underlying cause is essential for selecting the appropriate treatment strategy. Many conditions require evaluation by an endocrine specialist.\n<\/p>\n
\nCommon Causes<\/h3>\n
\n Hormonal disorders involving the thyroid, parathyroid, or adrenal glands can significantly affect bone health. Chronic kidney disease, vitamin D or calcium deficiency, and long\u2011term steroid use are also common contributors. Some disorders are inherited or related to cancer or cancer treatment.\n <\/p>\n
\n- Hormonal imbalances (thyroid, parathyroid, adrenal)<\/li>\n
- Chronic kidney disease<\/li>\n
- Vitamin D or calcium deficiency<\/li>\n
- Genetic conditions<\/li>\n
- Long\u2011term steroid use<\/li>\n
- Cancer or cancer treatment<\/li>\n
- Malabsorption disorders<\/li>\n<\/ul>\n<\/div>\n
How Bone Disorders Are Diagnosed<\/h2>\n
\nDiagnosis typically involves a comprehensive endocrine and metabolic evaluation. Our team uses laboratory testing, imaging, and specialized studies to determine the cause of bone abnormalities and guide treatment. Early diagnosis helps prevent complications and supports long\u2011term bone health.\n<\/p>\n
\nLaboratory Testing<\/h3>\n
\n Blood and urine tests help identify abnormalities in calcium, phosphorus, vitamin D, and parathyroid hormone (PTH). Kidney function and bone turnover markers may also be evaluated. These tests help determine whether endocrine or metabolic factors are contributing to bone disease.\n <\/p>\n
\n- Calcium and phosphorus levels<\/li>\n
- Vitamin D levels<\/li>\n
- Parathyroid hormone (PTH)<\/li>\n
- Kidney function tests<\/li>\n
- Bone turnover markers<\/li>\n<\/ul>\n
Imaging<\/h3>\n![\"Bone](\"https:\/\/www.saintjohnscancer.org\/endocrine\/wp-content\/uploads\/sites\/3\/2026\/05\/Bone-Density-DEXA-Scan-of-the-hip-and-spine.jpg\")
Bone density evaluation of the hip and spine can help determine the extent of bone loss.<\/figcaption><\/figure>\n\n Imaging studies help assess bone structure, density, and integrity. Depending on the condition, evaluation may include DEXA scans, X\u2011rays, CT, or MRI. These tools help identify fractures, deformities, or abnormal bone remodeling.\n <\/p>\n
\n- Bone density testing (DEXA)<\/li>\n
- X\u2011rays<\/li>\n
- CT or MRI when indicated<\/li>\n<\/ul>\n
Specialized Evaluation<\/h3>\n
\n In select cases, genetic testing or advanced metabolic studies may be recommended. These evaluations help diagnose rare or inherited bone disorders and guide personalized treatment plans.\n <\/p>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-gray-l","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":"
Treatment and Management<\/h2>\n
\nTreatment depends on the specific disorder and its underlying cause. Our team develops individualized care plans that may include nutritional support, medication, hormonal therapy, or management of related endocrine or kidney disease. Long\u2011term monitoring helps ensure treatment remains effective over time.\n<\/p>\n
\nTreatment Options<\/h3>\n
\n Management may involve correcting vitamin or mineral deficiencies, regulating hormone levels, or using medications that influence bone remodeling. When bone disease is related to endocrine or kidney conditions, treating the underlying disorder is essential for improving bone health.\n <\/p>\n
\n- Vitamin or mineral supplementation<\/li>\n
- Hormonal therapy<\/li>\n
- Medications that regulate bone remodeling<\/li>\n
- Management of endocrine or kidney disease<\/li>\n
- Long\u2011term monitoring of bone density and labs<\/li>\n<\/ul>\n<\/div>\n
When to See a Specialist<\/h2>\n![\"Evaluation](\"https:\/\/www.saintjohnscancer.org\/endocrine\/wp-content\/uploads\/sites\/3\/2026\/05\/Evaluattion-of-osteoporosis-conditions.jpg\")
Our endocrine specialists can effectively evaluate a variety of bone conditions and coordinate your care accordingly.<\/figcaption><\/figure>\n\nEvaluation by an endocrine specialist is recommended when bone symptoms are unexplained, recurrent, or associated with abnormal laboratory findings. Early assessment helps prevent complications and ensures appropriate treatment.\n<\/p>\n
\nSigns You May Need Evaluation<\/h3>\n
\n You should consider seeing a specialist if you experience recurrent fractures, persistent bone pain, or abnormal calcium or phosphate levels. Individuals with endocrine or kidney\u2011related bone disease may also benefit from specialized care.\n <\/p>\n
\n- Recurrent fractures<\/li>\n
- Persistent or unexplained bone pain<\/li>\n
- Abnormal calcium or phosphate levels<\/li>\n
- Bone disease related to endocrine or kidney conditions<\/li>\n
- A rare or unclear bone diagnosis<\/li>\n<\/ul>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-gray-l","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":"
Frequently Asked Questions<\/h2>\n
\nPatients often have questions about how these disorders differ from osteoporosis, how they are treated, and when to seek care. Below are answers to some of the most common concerns.\n<\/p>\n
\nAre these bone disorders the same as osteoporosis?<\/h3>\n
\n No. Osteoporosis affects bone density, while other bone disorders may involve bone structure, mineralization, or metabolism. Each condition requires a different diagnostic and treatment approach.\n <\/p>\n
Can these bone disorders be treated?<\/h3>\n
\n Many bone disorders can be effectively managed once the underlying cause is identified. Treatment may include medication, nutritional support, or management of endocrine or kidney disease.\n <\/p>\n
Do bone metastases require endocrine care?<\/h3>\n
\n Endocrinology may be involved in managing bone health, calcium levels, and fracture risk in coordination with oncology teams. This collaborative approach helps support overall bone stability and metabolic balance.\n <\/p>\n
Is fibrous dysplasia inherited?<\/h3>\n
\n Most cases are sporadic and not inherited, though some forms are associated with endocrine syndromes. Genetic evaluation may be recommended in select cases.\n <\/p>\n<\/div>\n
Get Answers to Your Questions<\/h2>\n
The Endocrine Center of Excellence provides expert evaluation and long\u2011term management for complex bone disorders. Our team works closely with specialists across Saint John\u2019s Health Center to ensure comprehensive, compassionate care for every patient.\n<\/p>\n
![\"Endocrine](\"https:\/\/www.saintjohnscancer.org\/endocrine\/wp-content\/uploads\/sites\/3\/2026\/05\/Doctors-Rose-Lin-and-Sarah-Rettinger-Endocrinologists-copy.jpg\"\n)
<\/p>\n
Rose Lin, MD, and Sarah Rettinger, MD, – Endocrinologists at Saint John’s Health Center in Santa Monica, CA.<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-gray-l","layer_id":""},{"acf_fc_layout":"layer_two_column","layer_label":"","layer_headline":"","layer_intro":"","layer_content_left":"If you have questions regarding bone disorders, symptoms, or treatment, please call today. Click here<\/u><\/a> to request an appointment.<\/p>\n","layer_content_right":"
\nOther bone disorders refer to less common conditions that disrupt normal bone formation, remodeling, or mineralization. Unlike osteoporosis\u2014which primarily involves loss of bone density\u2014these disorders may affect bone structure, mineral balance, or the way bone tissue is built and repaired. Many are closely linked to endocrine, metabolic, renal, or oncologic processes, making accurate diagnosis essential for effective treatment.\n<\/p>\n
How These Disorders Affect Bone Health<\/h3>\n
\n These conditions may alter the shape, strength, or mineral content of bone, leading to pain, deformity, or increased fracture risk. Some disorders interfere with calcium or phosphate regulation, while others affect the way bone cells remodel tissue. Understanding the underlying cause helps guide treatment and long\u2011term monitoring.\n <\/p>\n
Why Specialized Evaluation Matters<\/h3>\n
\n Because many bone disorders overlap with endocrine or metabolic conditions, evaluation by an endocrine specialist is often necessary. Our team works closely with nephrology, oncology, and genetics when needed to ensure a complete and accurate diagnosis.\n <\/p>\n<\/div>\n
Types of Bone Disorders We Evaluate<\/h2>\n
\nA variety of metabolic and structural bone disorders fall under this category. Each condition affects bone differently and requires a tailored approach to diagnosis and treatment. Below are some of the most common disorders evaluated by our endocrine team.\n<\/p>\n
Osteomalacia<\/h3>\nOsteomalacia can result in pelvic deformities, including softening of the pelvic girdle creating inward pressure from the femoral heads.<\/figcaption><\/figure>\n\n Osteomalacia occurs when bones fail to mineralize properly, often due to vitamin D deficiency, malabsorption, or chronic kidney disease. This leads to soft, weakened bones that may cause pain, muscle weakness, or fractures. Treatment focuses on correcting the underlying deficiency or metabolic imbalance.\n <\/p>\n
Paget\u2019s Disease of Bone<\/h3>\n
\n Paget\u2019s disease is a chronic condition in which bone remodeling occurs too rapidly, producing enlarged but structurally weak bone. It most commonly affects the spine, pelvis, skull, and long bones. Early diagnosis and treatment can help prevent complications such as fractures or arthritis.\n <\/p>\n
Renal Osteodystrophy<\/h3>\n
\n Renal osteodystrophy is a bone disorder related to chronic kidney disease, caused by imbalances in calcium, phosphorus, and parathyroid hormone (PTH). Because it is closely tied to endocrine function, evaluation often includes assessment of parathyroid disease<\/a> and mineral metabolism.\n <\/p>\nHypophosphatemia<\/h3>\n
\n Hypophosphatemia is characterized by low phosphate levels, which can impair bone strength and lead to fractures or bone pain. It may be inherited or acquired and often requires specialized metabolic evaluation to determine the cause.\n <\/p>\n
Osteoporosis<\/h3>\n
\n Osteoporosis develops due to a combination of biological, hormonal, and lifestyle factors. See Osteoporosis<\/u><\/a> for additional information.\n <\/p>\n<\/div>\nBone Metastases from Cancer<\/h2>\n
\nBone metastases occur when cancer spreads from its original site to the bone. Although not a primary bone disorder, metastases can mimic metabolic bone disease on imaging or laboratory testing. Breast, prostate, lung, kidney, and thyroid cancers are among the most common sources of bone metastases.\n<\/p>\n
\nHow Bone Metastases Affect Bone Health<\/h3>\nBone metastasis from cancer can present one or more symptoms such as bone pain or fractures.<\/figcaption><\/figure>\n\n When cancer cells spread to bone, they can weaken the bone structure and increase the risk of fractures. Patients may experience bone pain, spinal cord compression, or elevated calcium levels. These complications require prompt evaluation and coordinated care.\n <\/p>\n
\n- Bone pain<\/li>\n
- Fractures<\/li>\n
- Spinal cord compression<\/li>\n
- Elevated calcium levels<\/li>\n<\/ul>\n
Coordinated Care With Oncology<\/h3>\n
\n Because bone metastases can resemble metabolic bone disorders, endocrine specialists often collaborate with oncology teams to evaluate bone health, manage calcium abnormalities, and reduce fracture risk. This multidisciplinary approach ensures comprehensive care for patients with cancer\u2011related bone involvement.\n <\/p>\n<\/div>\n
Fibrous Dysplasia<\/h2>\n
\nFibrous dysplasia is a rare bone disorder in which normal bone is replaced with fibrous tissue, leading to weakened bone structure and potential deformity. It may involve a single bone (monostotic) or multiple bones (polyostotic) and can be associated with endocrine abnormalities in certain syndromic forms.\n<\/p>\n
\nSymptoms of Fibrous Dysplasia<\/h3>\n
\n Symptoms vary depending on the bones involved and may include pain, fractures, deformity, or limb length differences. Some individuals have mild disease, while others require long\u2011term monitoring and supportive care.\n <\/p>\n
\n- Bone pain<\/li>\n
- Fractures<\/li>\n
- Bone deformity<\/li>\n
- Limb length differences<\/li>\n<\/ul>\n
How It Is Managed<\/h3>\n
\n Management focuses on monitoring bone integrity, reducing symptoms, and addressing associated hormonal conditions when present. Our endocrine team evaluates for related disorders and coordinates care with orthopedics and genetics when needed.\n <\/p>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-none","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":"
Signs and Symptoms of Bone Disorders<\/h2>\n
\nBone disorders can present in many ways depending on the underlying cause and severity. Some individuals experience noticeable symptoms, while others are diagnosed after abnormal imaging or laboratory findings. Recognizing early signs can help prevent complications.\n<\/p>\n
\nCommon Symptoms<\/h3>\nYour primary care physician may refer you to an endocrine specialist to address bone related conditions.<\/figcaption><\/figure>\n\n Symptoms may include persistent bone pain, recurrent fractures, muscle weakness, or skeletal deformities. Children and adolescents may experience delayed growth or difficulty walking. Any unexplained bone symptoms should prompt evaluation.\n <\/p>\n
\n- Persistent bone pain or tenderness<\/li>\n
- Recurrent or unexplained fractures<\/li>\n
- Muscle weakness<\/li>\n
- Skeletal deformities<\/li>\n
- Loss of height<\/li>\n
- Difficulty walking<\/li>\n
- Delayed growth in children or adolescents<\/li>\n<\/ul>\n<\/div>\n
Causes and Risk Factors<\/h2>\n
\nBone disorders may arise from hormonal imbalances, metabolic abnormalities, chronic disease, or genetic factors. Identifying the underlying cause is essential for selecting the appropriate treatment strategy. Many conditions require evaluation by an endocrine specialist.\n<\/p>\n
\nCommon Causes<\/h3>\n
\n Hormonal disorders involving the thyroid, parathyroid, or adrenal glands can significantly affect bone health. Chronic kidney disease, vitamin D or calcium deficiency, and long\u2011term steroid use are also common contributors. Some disorders are inherited or related to cancer or cancer treatment.\n <\/p>\n
\n- Hormonal imbalances (thyroid, parathyroid, adrenal)<\/li>\n
- Chronic kidney disease<\/li>\n
- Vitamin D or calcium deficiency<\/li>\n
- Genetic conditions<\/li>\n
- Long\u2011term steroid use<\/li>\n
- Cancer or cancer treatment<\/li>\n
- Malabsorption disorders<\/li>\n<\/ul>\n<\/div>\n
How Bone Disorders Are Diagnosed<\/h2>\n
\nDiagnosis typically involves a comprehensive endocrine and metabolic evaluation. Our team uses laboratory testing, imaging, and specialized studies to determine the cause of bone abnormalities and guide treatment. Early diagnosis helps prevent complications and supports long\u2011term bone health.\n<\/p>\n
\nLaboratory Testing<\/h3>\n
\n Blood and urine tests help identify abnormalities in calcium, phosphorus, vitamin D, and parathyroid hormone (PTH). Kidney function and bone turnover markers may also be evaluated. These tests help determine whether endocrine or metabolic factors are contributing to bone disease.\n <\/p>\n
\n- Calcium and phosphorus levels<\/li>\n
- Vitamin D levels<\/li>\n
- Parathyroid hormone (PTH)<\/li>\n
- Kidney function tests<\/li>\n
- Bone turnover markers<\/li>\n<\/ul>\n
Imaging<\/h3>\nBone density evaluation of the hip and spine can help determine the extent of bone loss.<\/figcaption><\/figure>\n\n Imaging studies help assess bone structure, density, and integrity. Depending on the condition, evaluation may include DEXA scans, X\u2011rays, CT, or MRI. These tools help identify fractures, deformities, or abnormal bone remodeling.\n <\/p>\n
\n- Bone density testing (DEXA)<\/li>\n
- X\u2011rays<\/li>\n
- CT or MRI when indicated<\/li>\n<\/ul>\n
Specialized Evaluation<\/h3>\n
\n In select cases, genetic testing or advanced metabolic studies may be recommended. These evaluations help diagnose rare or inherited bone disorders and guide personalized treatment plans.\n <\/p>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-gray-l","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":"
Treatment and Management<\/h2>\n
\nTreatment depends on the specific disorder and its underlying cause. Our team develops individualized care plans that may include nutritional support, medication, hormonal therapy, or management of related endocrine or kidney disease. Long\u2011term monitoring helps ensure treatment remains effective over time.\n<\/p>\n
\nTreatment Options<\/h3>\n
\n Management may involve correcting vitamin or mineral deficiencies, regulating hormone levels, or using medications that influence bone remodeling. When bone disease is related to endocrine or kidney conditions, treating the underlying disorder is essential for improving bone health.\n <\/p>\n
\n- Vitamin or mineral supplementation<\/li>\n
- Hormonal therapy<\/li>\n
- Medications that regulate bone remodeling<\/li>\n
- Management of endocrine or kidney disease<\/li>\n
- Long\u2011term monitoring of bone density and labs<\/li>\n<\/ul>\n<\/div>\n
When to See a Specialist<\/h2>\nOur endocrine specialists can effectively evaluate a variety of bone conditions and coordinate your care accordingly.<\/figcaption><\/figure>\n\nEvaluation by an endocrine specialist is recommended when bone symptoms are unexplained, recurrent, or associated with abnormal laboratory findings. Early assessment helps prevent complications and ensures appropriate treatment.\n<\/p>\n
\nSigns You May Need Evaluation<\/h3>\n
\n You should consider seeing a specialist if you experience recurrent fractures, persistent bone pain, or abnormal calcium or phosphate levels. Individuals with endocrine or kidney\u2011related bone disease may also benefit from specialized care.\n <\/p>\n
\n- Recurrent fractures<\/li>\n
- Persistent or unexplained bone pain<\/li>\n
- Abnormal calcium or phosphate levels<\/li>\n
- Bone disease related to endocrine or kidney conditions<\/li>\n
- A rare or unclear bone diagnosis<\/li>\n<\/ul>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-gray-l","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":"
Frequently Asked Questions<\/h2>\n
\nPatients often have questions about how these disorders differ from osteoporosis, how they are treated, and when to seek care. Below are answers to some of the most common concerns.\n<\/p>\n
\nAre these bone disorders the same as osteoporosis?<\/h3>\n
\n No. Osteoporosis affects bone density, while other bone disorders may involve bone structure, mineralization, or metabolism. Each condition requires a different diagnostic and treatment approach.\n <\/p>\n
Can these bone disorders be treated?<\/h3>\n
\n Many bone disorders can be effectively managed once the underlying cause is identified. Treatment may include medication, nutritional support, or management of endocrine or kidney disease.\n <\/p>\n
Do bone metastases require endocrine care?<\/h3>\n
\n Endocrinology may be involved in managing bone health, calcium levels, and fracture risk in coordination with oncology teams. This collaborative approach helps support overall bone stability and metabolic balance.\n <\/p>\n
Is fibrous dysplasia inherited?<\/h3>\n
\n Most cases are sporadic and not inherited, though some forms are associated with endocrine syndromes. Genetic evaluation may be recommended in select cases.\n <\/p>\n<\/div>\n
Get Answers to Your Questions<\/h2>\n
The Endocrine Center of Excellence provides expert evaluation and long\u2011term management for complex bone disorders. Our team works closely with specialists across Saint John\u2019s Health Center to ensure comprehensive, compassionate care for every patient.\n<\/p>\n
<\/p>\n
Rose Lin, MD, and Sarah Rettinger, MD, – Endocrinologists at Saint John’s Health Center in Santa Monica, CA.<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-gray-l","layer_id":""},{"acf_fc_layout":"layer_two_column","layer_label":"","layer_headline":"","layer_intro":"","layer_content_left":"If you have questions regarding bone disorders, symptoms, or treatment, please call today. Click here<\/u><\/a> to request an appointment.<\/p>\n","layer_content_right":"
\n Osteomalacia occurs when bones fail to mineralize properly, often due to vitamin D deficiency, malabsorption, or chronic kidney disease. This leads to soft, weakened bones that may cause pain, muscle weakness, or fractures. Treatment focuses on correcting the underlying deficiency or metabolic imbalance.\n <\/p>\n
Paget\u2019s Disease of Bone<\/h3>\n
\n Paget\u2019s disease is a chronic condition in which bone remodeling occurs too rapidly, producing enlarged but structurally weak bone. It most commonly affects the spine, pelvis, skull, and long bones. Early diagnosis and treatment can help prevent complications such as fractures or arthritis.\n <\/p>\n
Renal Osteodystrophy<\/h3>\n
\n Renal osteodystrophy is a bone disorder related to chronic kidney disease, caused by imbalances in calcium, phosphorus, and parathyroid hormone (PTH). Because it is closely tied to endocrine function, evaluation often includes assessment of parathyroid disease<\/a> and mineral metabolism.\n <\/p>\n \n Hypophosphatemia is characterized by low phosphate levels, which can impair bone strength and lead to fractures or bone pain. It may be inherited or acquired and often requires specialized metabolic evaluation to determine the cause.\n <\/p>\n \n Osteoporosis develops due to a combination of biological, hormonal, and lifestyle factors. See Osteoporosis<\/u><\/a> for additional information.\n <\/p>\n<\/div>\n \nBone metastases occur when cancer spreads from its original site to the bone. Although not a primary bone disorder, metastases can mimic metabolic bone disease on imaging or laboratory testing. Breast, prostate, lung, kidney, and thyroid cancers are among the most common sources of bone metastases.\n<\/p>\n \n When cancer cells spread to bone, they can weaken the bone structure and increase the risk of fractures. Patients may experience bone pain, spinal cord compression, or elevated calcium levels. These complications require prompt evaluation and coordinated care.\n <\/p>\n \n Because bone metastases can resemble metabolic bone disorders, endocrine specialists often collaborate with oncology teams to evaluate bone health, manage calcium abnormalities, and reduce fracture risk. This multidisciplinary approach ensures comprehensive care for patients with cancer\u2011related bone involvement.\n <\/p>\n<\/div>\n \nFibrous dysplasia is a rare bone disorder in which normal bone is replaced with fibrous tissue, leading to weakened bone structure and potential deformity. It may involve a single bone (monostotic) or multiple bones (polyostotic) and can be associated with endocrine abnormalities in certain syndromic forms.\n<\/p>\n \n Symptoms vary depending on the bones involved and may include pain, fractures, deformity, or limb length differences. Some individuals have mild disease, while others require long\u2011term monitoring and supportive care.\n <\/p>\n \n Management focuses on monitoring bone integrity, reducing symptoms, and addressing associated hormonal conditions when present. Our endocrine team evaluates for related disorders and coordinates care with orthopedics and genetics when needed.\n <\/p>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-none","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":" \nBone disorders can present in many ways depending on the underlying cause and severity. Some individuals experience noticeable symptoms, while others are diagnosed after abnormal imaging or laboratory findings. Recognizing early signs can help prevent complications.\n<\/p>\n \n Symptoms may include persistent bone pain, recurrent fractures, muscle weakness, or skeletal deformities. Children and adolescents may experience delayed growth or difficulty walking. Any unexplained bone symptoms should prompt evaluation.\n <\/p>\n \nBone disorders may arise from hormonal imbalances, metabolic abnormalities, chronic disease, or genetic factors. Identifying the underlying cause is essential for selecting the appropriate treatment strategy. Many conditions require evaluation by an endocrine specialist.\n<\/p>\n \n Hormonal disorders involving the thyroid, parathyroid, or adrenal glands can significantly affect bone health. Chronic kidney disease, vitamin D or calcium deficiency, and long\u2011term steroid use are also common contributors. Some disorders are inherited or related to cancer or cancer treatment.\n <\/p>\n \nDiagnosis typically involves a comprehensive endocrine and metabolic evaluation. Our team uses laboratory testing, imaging, and specialized studies to determine the cause of bone abnormalities and guide treatment. Early diagnosis helps prevent complications and supports long\u2011term bone health.\n<\/p>\n \n Blood and urine tests help identify abnormalities in calcium, phosphorus, vitamin D, and parathyroid hormone (PTH). Kidney function and bone turnover markers may also be evaluated. These tests help determine whether endocrine or metabolic factors are contributing to bone disease.\n <\/p>\n \n Imaging studies help assess bone structure, density, and integrity. Depending on the condition, evaluation may include DEXA scans, X\u2011rays, CT, or MRI. These tools help identify fractures, deformities, or abnormal bone remodeling.\n <\/p>\n \n In select cases, genetic testing or advanced metabolic studies may be recommended. These evaluations help diagnose rare or inherited bone disorders and guide personalized treatment plans.\n <\/p>\n<\/div>\n","layer_is_content_auto_columns":false,"sidebar_position":"right","widgets":false,"layer_icon":"","layer_icon_position":"left","layer_background_color":"bg-gray-l","layer_id":""},{"acf_fc_layout":"layer_content_sidebar","layer_label":"","layer_headline":"","layer_intro":"","layer_content":" \nTreatment depends on the specific disorder and its underlying cause. Our team develops individualized care plans that may include nutritional support, medication, hormonal therapy, or management of related endocrine or kidney disease. Long\u2011term monitoring helps ensure treatment remains effective over time.\n<\/p>\n \n Management may involve correcting vitamin or mineral deficiencies, regulating hormone levels, or using medications that influence bone remodeling. When bone disease is related to endocrine or kidney conditions, treating the underlying disorder is essential for improving bone health.\n <\/p>\n \nEvaluation by an endocrine specialist is recommended when bone symptoms are unexplained, recurrent, or associated with abnormal laboratory findings. Early assessment helps prevent complications and ensures appropriate treatment.\n<\/p>\n \n You should consider seeing a specialist if you experience recurrent fractures, persistent bone pain, or abnormal calcium or phosphate levels. Individuals with endocrine or kidney\u2011related bone disease may also benefit from specialized care.\n <\/p>\n \nPatients often have questions about how these disorders differ from osteoporosis, how they are treated, and when to seek care. Below are answers to some of the most common concerns.\n<\/p>\n \n No. Osteoporosis affects bone density, while other bone disorders may involve bone structure, mineralization, or metabolism. Each condition requires a different diagnostic and treatment approach.\n <\/p>\n \n Many bone disorders can be effectively managed once the underlying cause is identified. Treatment may include medication, nutritional support, or management of endocrine or kidney disease.\n <\/p>\n \n Endocrinology may be involved in managing bone health, calcium levels, and fracture risk in coordination with oncology teams. This collaborative approach helps support overall bone stability and metabolic balance.\n <\/p>\n \n Most cases are sporadic and not inherited, though some forms are associated with endocrine syndromes. Genetic evaluation may be recommended in select cases.\n <\/p>\n<\/div>\n The Endocrine Center of Excellence provides expert evaluation and long\u2011term management for complex bone disorders. Our team works closely with specialists across Saint John\u2019s Health Center to ensure comprehensive, compassionate care for every patient.\n<\/p>\n If you have questions regarding bone disorders, symptoms, or treatment, please call today. Click here<\/u><\/a> to request an appointment.<\/p>\n","layer_content_right":"Hypophosphatemia<\/h3>\n
Osteoporosis<\/h3>\n
Bone Metastases from Cancer<\/h2>\n
How Bone Metastases Affect Bone Health<\/h3>\n
\n
Coordinated Care With Oncology<\/h3>\n
Fibrous Dysplasia<\/h2>\n
Symptoms of Fibrous Dysplasia<\/h3>\n
\n
How It Is Managed<\/h3>\n
Signs and Symptoms of Bone Disorders<\/h2>\n
Common Symptoms<\/h3>\n
\n
Causes and Risk Factors<\/h2>\n
Common Causes<\/h3>\n
\n
How Bone Disorders Are Diagnosed<\/h2>\n
Laboratory Testing<\/h3>\n
\n
Imaging<\/h3>\n
\n
Specialized Evaluation<\/h3>\n
Treatment and Management<\/h2>\n
Treatment Options<\/h3>\n
\n
When to See a Specialist<\/h2>\n
Signs You May Need Evaluation<\/h3>\n
\n
Frequently Asked Questions<\/h2>\n
Are these bone disorders the same as osteoporosis?<\/h3>\n
Can these bone disorders be treated?<\/h3>\n
Do bone metastases require endocrine care?<\/h3>\n
Is fibrous dysplasia inherited?<\/h3>\n
Get Answers to Your Questions<\/h2>\n
<\/p>\n